Ptc Therapeutics (PTCT) Capital Expenditures Growth (5y) (2017 - 2026)
Ptc Therapeutics (PTCT) Capital Expenditures Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.73% |
| Dec 31, 2025 | 9.42% |
| Sep 30, 2025 | 0.81% |
| Jun 30, 2025 | -9.42% |
| Mar 31, 2025 | -22.13% |
| Dec 31, 2024 | -20.80% |
| Sep 30, 2024 | -34.27% |
| Jun 30, 2024 | -41.70% |
| Mar 31, 2024 | 27.33% |
| Dec 31, 2023 | 11.75% |
| Sep 30, 2023 | 18.54% |
| Jun 30, 2023 | 87.68% |
| Mar 31, 2023 | -43.33% |
| Dec 31, 2022 | 20.80% |
| Sep 30, 2022 | -41.20% |
| Jun 30, 2022 | 89.72% |
| Mar 31, 2022 | 110.56% |
| Dec 31, 2021 | 47.83% |
| Sep 30, 2021 | 85.65% |
| Jun 30, 2021 | 280.48% |